alexa Immunotherapy: An Answer for Cancer?

Journal of Cancer Clinical Trials
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Immunotherapy: An Answer for Cancer?

C.V.Patel1 and V.C.Patel2*

1S.G.S.Medical College and K.E.M. Hospital, Mumbai, India

2Department of Surgery, V.N.Desai Municipal General Hospital, Mumbai, India

*Corresponding Author:
Vitthal C. Patel
Speciality Medical Consultant
Department of Surgery
V.N.Desai Municipal General Hospital, Mumbai, India
Tel : +919820735901
E-mail: [email protected]

Received Date: May 03, 2017; Accepted Date: May 16, 2017; Published Date: May 22, 2017

Citation: C.V.Patel and V.C.Patel (2017) Immunotherapy: An Answer for Cancer?. J Cancer Clin Trials 2:131.

Copyright: © 2017 Patel C.V, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Objective: Conventional treatment offers no solution to advanced cancer patients in developing countries like India. The aim was to find out if the history of Indian and world medicine reveals any answers for such patients.

Methods: The evidence based therapies tried in clinical cases were recorded from world literature on oncology. The only selection criterion was advance cancer patients in whom conventional treatment was tried and failed.

Results: The parameters of results were mainly a) palliation of symptoms b) increase in life span c) disease free survival. The methods tried in literature were used in our patients and results of original authors and our results were compared and recorded. Pathophysiology of each method was discussed independently.

Conclusions: Best results were obtained where conventional destructive methods were complimented with boost to patient’s immunity. Principles of Dr Jenner’s vaccine therapy were utilised. Though histologically, patients may suffer from one pathology (i.e. Gastric cancer), each patient may give different immunological response to immunotherapy. Hence each patient was immunological stimulated against his own tumour by totally or partially destroying his tumour in situ with physical agents like patients own urine, or heat, anoxia and powerful allergens from plant extracts. Our survival rates are 3% over 10 years of disease control. In other 97% patients, about 30% had substantial palliation. Rest died at home shortly and follow up was not possible.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords